ANGO stock news

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more
AngioDyamics (ANGO) gains from solid segmental contributions in fourth-quarter fiscal 2019. Read more

AngioDynamics (ANGO) Lags Q4 Earnings Estimates

12:25pm, Wednesday, 10'th Jul 2019
AngioDynamics (ANGO) delivered earnings and revenue surprises of -3.85% and 3.72%, respectively, for the quarter ended May 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
AngioDynamics (ANGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
The NAMIC fluid management portfolio sale clears all of AngioDynamics' (ANGO) outstanding debt. Read more
AngioDynamics' (ANGO) pilot study is intended to support the approval of a future PMA in the United States. Read more
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more
Dedicated investors are constantly on the lookout for a bargain when it comes to stock picking. As of late, investors have been taking notice of AngioDynamics, Inc. (NASDAQ:ANGO) shares. During recent Read more
Investors tracking technical indicators on shares of Angiodynamics Inc (ANGO) may be focusing in on the 20-Day Bollinger Bands signal. After a recent check, we have noted that the current reading is B Read more
Interested investors might be taking a look at the medium range signals for Angiodynamics Inc (ANGO). The reading from the 40-day commodity channel index is currently Buy. The CCI indicator is mainly Read more

Proudly made at

ROCKIT